1. Cost-of-Illness Studies

   • Marc A. Koopmanschap

   Current Opinion 22 September 2012 Pages: 143 - 148

2. Update on Clinical Research Summit in US

   • Jay Moskowitz
   • James N. Thompson

   Current Opinion 22 September 2012 Pages: 149 - 150

3. The Role of Clinical Pathways in Reducing the Economic Burden of Stroke

   • Douglas J. Lanska

   Leading Article 22 September 2012 Pages: 151 - 158

4. Reporting Format for Economic Evaluation

   • Mark J. C. Nuijten
   • Mark J. A. Brorens
   • Marja H. Pronk

   Leading Article 22 September 2012 Pages: 159 - 163

5. Cost Effectiveness of Prophylaxis for Opportunistic Infections in AIDS

   • Kenneth A. Freedberg
   • A. David Paltiel

   Review Article 22 September 2012 Pages: 165 - 173

6. A Review of the Pharmacoeconomics of Pharmaceutical Care

   • Richard J. Plumridge
   • Richard E. Wojnar-Horton

   Review Article 22 September 2012 Pages: 175 - 189

7. Choice of NSAID and Management Strategy in Rheumatoid Arthritis and Osteoarthritis

   • Chris J. McCabe
   • Ron L. Akehurst
   • Ian Haslock

   Original Research Article 22 September 2012 Pages: 191 - 199

8. Quality of Life Following a Change in Therapy for Diabetes Mellitus

   • Mirjana Pibernik-Okanović
   • Silvija Szabo
   • Željko Metelko

   Original Research Article 22 September 2012 Pages: 201 - 207

9. Cost Effectiveness of Screening for Subclinical Hypothyroidism in the Elderly

   • Massimo Bona
   • Ferruccio Santini
   • Roberto Grilli

   Original Research Article 22 September 2012 Pages: 209 - 216

10. Pravastatin

    • Allan J. Coukell
    • Michelle I. Wilde

    Adis Pharmacoeconomic Drug Evaluation 22 September 2012 Pages: 217 - 236